Guidelines on clinical presentation and management of nondystrophic myotonias. [electronic resource]
Producer: 20201123Description: 430-444 p. digitalISSN:- 1097-4598
- Acetazolamide -- therapeutic use
- Age of Onset
- Carbonic Anhydrase Inhibitors -- therapeutic use
- Chloride Channels -- genetics
- Electrodiagnosis
- Electromyography
- Fatigue -- physiopathology
- Genetic Testing
- Humans
- Lamotrigine -- therapeutic use
- Mexiletine -- therapeutic use
- Muscle Weakness -- physiopathology
- Muscle, Skeletal -- physiopathology
- Myalgia -- physiopathology
- Myotonia Congenita -- drug therapy
- Myotonic Disorders -- genetics
- NAV1.4 Voltage-Gated Sodium Channel -- genetics
- Practice Guidelines as Topic
- Ranolazine -- therapeutic use
- Sodium Channel Blockers -- therapeutic use
- Voltage-Gated Sodium Channel Blockers -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.